ANALYSIS USING MICROFLUIDIC PARTITIONING DEVICES
    3.
    发明申请
    ANALYSIS USING MICROFLUIDIC PARTITIONING DEVICES 审中-公开
    微流体分配装置的分析

    公开(公告)号:WO2007044091A3

    公开(公告)日:2007-11-15

    申请号:PCT/US2006021416

    申请日:2006-06-02

    Abstract: The invention relates to methods, reagents and devices for detection and characterization of nucleic acids, cells, and other biological samples. Assay method are provided in which a sample is partitioned into sub-samples, and analysis of the contents of the sub-samples carried out. The invention also provides microfluidic devices for conducting the assay. The invention also provides an analysis method using a universal primers and probes for amplification and detection.

    Abstract translation: 本发明涉及用于检测和表征核酸,细胞和其他生物样品的方法,试剂和装置。 提供了一种分析方法,其中将样品分成子样品,并分析所进行的子样品的含量。 本发明还提供用于进行测定的微流体装置。 本发明还提供了一种使用通用引物和探针进行扩增和检测的分析方法。

    MICROFLUIDIC PARTICLE-ANALYSIS SYSTEMS

    公开(公告)号:CA2480728A1

    公开(公告)日:2003-10-16

    申请号:CA2480728

    申请日:2003-04-01

    Applicant: FLUIDIGM CORP

    Abstract: The invention provides systems (2000), including microfluidic mechanisms, methods, and kits, for the microfluidic manipulation and/or detection of particles, such as cells and/or beads. These mechanisms may enable controlle d input, movement/positioning, retention/localization, treatment, measurement, release, and/or output of particles. Furthermore, these mechanisms may be combined in any suitable order and/or employed for any number of suitable times in the system to allow particles to be sorted, cultured, mixed, treate d, and/or assayed, among others. These combinations may allow the response of particles to treatment to be measured on a shorter time scale than was previously possible. Therefore, systems of the invention may allow a broad range of cell and particle assays, such as drug screens, cell characterizations, research studies, and/or clinical analyses, among others, to be scaled down to microfluidic size. Such scaled-down assays may use less sample and reagent, may be less labor intensive, and/or may be more informative than comparable macrofluidic assays.

Patent Agency Ranking